Female-specific hypertension loci on rat chromosome 13

Hypertension

Volumn 62, Issue 3, 2013, Pages 557-563

  Hoffman, Matthew J ^a   Flister, Michael J ^a   Nunez, Lizbeth ^a   Xiao, Bing ^a   Greene, Andrew S ^a   Jacob, Howard J ^a   Moreno, Carol ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

blood pressure; genetics; hypertension; kidney; sex

Indexed keywords

ALBUMIN;

3' UNTRANSLATED REGION; ALBUMINURIA; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CHROMOSOME 13; CONGENIC STRAIN; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC CODE; HEREDITARY HYPERTENSION; HYPERTENSION; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY MEDULLA; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEQUENCE ANALYSIS; SEX DIFFERENCE; SODIUM INTAKE; SODIUM RESTRICTION; URINALYSIS;

BLOOD PRESSURE; GENETICS; HYPERTENSION; KIDNEY; SEX;

ALLELES; ANIMALS; BLOOD PRESSURE; CHROMOSOME MAPPING; CHROMOSOMES, MAMMALIAN; FEMALE; GENETIC LOCI; HYPERTENSION; KIDNEY; RATS; RATS, INBRED BN; RATS, INBRED DAHL; RENIN;

EID: 84883301077     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01708     Document Type: Article

References (60)

1. Cowley AW Jr. The genetic dissection of essential hypertension. Nat Rev Genet. 2006;7:829-840.
2. Kumar R, Nejatizadeh A, Arif E, Akhtar S, Gupta M, Tyagi S, Goyal AK, Jain SK, Qadar Pasha MA. Multi-locus interactions of vascular homeostasis genes in essential hypertension: A gender-based study. Clin Chim Acta. 2009;405:87-93.
3. Nakayama T, Kuroi N, Sano M, Tabara Y, Katsuya T, Ogihara T, Makita Y, Hata A, Yamada M, Takahashi N, Hirawa N, Umemura S, Miki T, Soma M. Mutation of the follicle-stimulating hormone receptor gene 5'-untranslated region associated with female hypertension. Hypertension. 2006;48:512-518.
4. Rana BK, Insel PA, Payne SH, Abel K, Beutler E, Ziegler MG, Schork NJ, O'Connor DT. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension. 2007;49:96-106.
5. Peter I, Shearman AM, Zucker DR, Schmid CH, Demissie S, Cupples LA, Larson MG, Vasan RS, D'Agostino RB, Karas RH, Mendelsohn ME, Housman DE, Levy D. Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens. 2005;23:2193-2200.
6. Wang X, Zhu H, Dong Y, Treiber FA, Snieder H. Effects of angiotensinogen and angiotensin II type I receptor genes on blood pressure and left ventricular mass trajectories in multiethnic youth. Twin Res Hum Genet. 2006;9:393-402.
7. Seda O, Tremblay J, Gaudet D, Brunelle PL, Gurau A, Merlo E, Pilote L, Orlov SN, Boulva F, Petrovich M, Kotchen TA, Cowley AW Jr, Hamet P. Systematic, genome-wide, sex-specific linkage of cardiovascular traits in French Canadians. Hypertension. 2008;51:1156-1162.
8. Moreno C, Kaldunski ML, Wang T, Roman RJ, Greene AS, Lazar J, Jacob HJ, Cowley AW Jr. Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat. Physiol Genomics. 2007;31:228-235.
9. Flister MJ, Prisco SZ, Sarkis AB, O'Meara CC, Hoffman M, Wendt-Andrae J, Moreno C, Lazar J, Jacob HJ. Identification of hypertension susceptibility loci on rat chromosome 12. Hypertension. 2012;60: 942-948.
10. Stodola TJ, de Resende MM, Sarkis AB, Didier DN, Jacob HJ, Huebner N, Hummel O, Saar K, Moreno C, Greene AS. Characterization of the genomic structure and function of regions influencing renin and angiogenesis in the SS rat. Physiol Genomics. 2011;43:808-817.
11. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92-105.
12. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics. 2010;26:2069-2070.
13. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: Server and survey. Nucleic Acids Res. 2002;30:3894-3900.
14. Yang C, Stingo FC, Ahn KW, et al. Increased proliferative cells in the medullary thick ascending limb of the loop of Henle in the Dahl saltsensitive rat. Hypertension. 2013;61:208-215.
15. Le Goff MM, Bishop PN. Focus on molecules: Opticin. Exp Eye Res. 2007;85:303-304.
16. Sullivan JC. Sex and the renin-angiotensin system: Inequality between the sexes in response to RAS stimulation and inhibition. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1220-R1226.
17. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37:1199-1208.
18. Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012;3:7.
19. Liu Y, Taylor NE, Lu L, Usa K, Cowley AW Jr, Ferreri NR, Yeo NC, Liang M. Renal medullary microRNAs in Dahl salt-sensitive rats: MiR-29b regulates several collagens and related genes. Hypertension. 2010;55:974-982.
20. Schaefer L. Small leucine-rich proteoglycans in kidney disease. J Am Soc Nephrol. 2011;22:1200-1207.
21. Le Goff MM, Sutton MJ, Slevin M, Latif A, Humphries MJ, Bishop PN. Opticin exerts its anti-angiogenic activity by regulating extracellular matrix adhesiveness. J Biol Chem. 2012;287:28027-28036.
22. Jeansson M, Granqvist AB, Nyström JS, Haraldsson B. Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice. Diabetologia. 2006;49:2200-2209.
23. Schaefer L, Raslik I, Grone HJ, Schonherr E, Macakova K, Ugorcakova J, Budny S, Schaefer RM, Kresse H. Small proteoglycans in human diabetic nephropathy: Discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J. 2001;15:559-561.
24. Kawakubo H, Carey JL, Brachtel E, Gupta V, Green JE, Walden PD, Maheswaran S. Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. Oncogene. 2004;23:8310-8319.
25. Karve TM, Rosen EM. B-cell translocation gene 2 (BTG2) stimulates cellular antioxidant defenses through the antioxidant transcription factor NFE2L2 in human mammary epithelial cells. J Biol Chem. 2012;287:31503-31514.
26. Franceschini N, MacCluer JW, Göring HH, Cole SA, Rose KM, Almasy L, Diego V, Laston S, Lee ET, Howard BV, Best LG, Fabsitz RR, Roman MJ, North KE. A quantitative trait loci-specific gene-by-sex interaction on systolic blood pressure among American Indians: The Strong Heart Family Study. Hypertension. 2006;48:266-270.
27. Ueno T, Tremblay J, Kunes J, Zicha J, Dobesová Z, Pausova Z, Deng AY, Sun Y, Jacob HJ, Hamet P. Gender-specific genetic determinants of blood pressure and organ weight: Pharmacogenetic approach. Physiol Res. 2003;52:689-700.
28. Moreno C, Dumas P, Kaldunski ML, Tonellato PJ, Greene AS, Roman RJ, Cheng Q, Wang Z, Jacob HJ, Cowley AW Jr. Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats. Physiol Genomics. 2003;15:243-257.
29. Herrera VL, Tsikoudakis A, Ponce LR, Matsubara Y, Ruiz-Opazo N. Sexspecific QTLs and interacting loci underlie salt-sensitive hypertension and target organ complications in Dahl S/jrHS hypertensive rats. Physiol Genomics. 2006;26:172-179.
30. Cicila GT, Rapp JP, Wang JM, St Lezin E, Ng SC, Kurtz TW. Linkage of 11 beta-hydroxylase mutations with altered steroid biosynthesis and blood pressure in the Dahl rat. Nat Genet. 1993;3:346-353.
31. Cicila GT, Dukhanina OI, Kurtz TW, Walder R, Garrett MR, Dene H, Rapp JP. Blood pressure and survival of a chromosome 7 congenic strain bred from Dahl rats. Mamm Genome. 1997;8:896-902.
32. Kaneko Y, Herrera VL, Didishvili T, Ruiz-Opazo N. Sex-specific effects of dual ET-1/ANG II receptor (Dear) variants in Dahl salt-sensitive/resistant hypertension rat model. Physiol Genomics. 2005;20:157-164.
33. Yagil C, Sapojnikov M, Kreutz R, Katni G, Lindpaintner K, Ganten D, Yagil Y. Salt susceptibility maps to chromosomes 1 and 17 with sex specificity in the Sabra rat model of hypertension. Hypertension. 1998;31:119-124.
34. Harris EL, Phelan EL, Thompson CM, Millar JA, Grigor MR. Heart mass and blood pressure have separate genetic determinants in the New Zealand genetically hypertensive (GH) rat. J Hypertens. 1995;13:397-404.
35. Clark JS, Jeffs B, Davidson AO, Lee WK, Anderson NH, Bihoreau MT, Brosnan MJ, Devlin AM, Kelman AW, Lindpaintner K, Dominiczak AF. Quantitative trait loci in genetically hypertensive rats. Possible sex specificity. Hypertension. 1996;28:898-906.
36. Carswell HV, Anderson NH, Clark JS, Graham D, Jeffs B, Dominiczak AF, Macrae IM. Genetic and gender influences on sensitivity to focal cerebral ischemia in the stroke-prone spontaneously hypertensive rat. Hypertension. 1999;33:681-685.
37. Xu CF, Chambers JA, Solomon E. Complex regulation of the BRCA1 gene. J Biol Chem. 1997;272:20994-20997.
38. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet. 1995;9:444-450.
39. Karmakar S, Foster EA, Smith CL. Estradiol downregulation of the tumor suppressor gene BTG2 requires estrogen receptor-alpha and the REA corepressor. Int J Cancer. 2009;124:1841-1851.
40. Carroll JS, Meyer CA, Song J, et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet. 2006;38:1289-1297.
41. Paruthiyil S, Cvoro A, Tagliaferri M, Cohen I, Shtivelman E, Leitman DC. Estrogen receptor beta causes a G2 cell cycle arrest by inhibiting Cdk1 activity through the regulation of Cyclin B1, Gadd45a, and Btg2. Breast Cancer Res Treatment. 2011;129:777-784.
42. Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M. Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res. 2007;67:6477-6483.
43. Mitra P, Pereira LA, Drabsch Y, Ramsay RG, Gonda TJ. Estrogen Receptor-Alpha Recruits P-Tefb to Overcome Transcriptional Pausing in Intron 1 of the Myb Gene. Nucleic Acids Res. 2012;40:5988-6000.
44. Giguère V. To ERR in the estrogen pathway. Trends Endocrinol Metab. 2002;13:220-225.
45. Yang T, Huang YG, Ye W, Hansen P, Schnermann JB, Briggs JP. Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice. Am J Physiol Renal Physiol. 2005;288:F1125-F1132.
46. Trieu VN, Uckun FM. Male-associated hypertension in LDL-R deficient mice. Biochem Biophys Res Commun. 1998;247:277-279.
47. Miller AA, Hislop AA, Vallance PJ, Haworth SG. Deletion of the eNOS gene has a greater impact on the pulmonary circulation of male than female mice. Am J Physiol Lung Cell Mol Physiol. 2005;289:L299-L306.
48. Pendergrass KD, Pirro NT, Westwood BM, Ferrario CM, Brosnihan KB, Chappell MC. Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats. Am J Physiol Heart Circ Physiol. 2008;295:H10-H20.
49. Kalamajski S, Oldberg A. The role of small leucine-rich proteoglycans in collagen fibrillogenesis. Matrix Biol. 2010;29:248-253.
50. Hildebrand A, Romarís M, Rasmussen LM, Heinegård D, Twardzik DR, Border WA, Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J. 1994;302 (Pt 2):527-534.
51. Rucci N, Rufo A, Alamanou M, Capulli M, Del Fattore A, Ahrman E, Capece D, Iansante V, Zazzeroni F, Alesse E, Heinegård D, Teti A. The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis. J Cell Biol. 2009;187:669-683.
52. Happonen KE, Sjöberg AP, Mörgelin M, Heinegård D, Blom AM. Complement inhibitor C4b-binding protein interacts directly with small glycoproteins of the extracellular matrix. J Immunol. 2009;182: 1518-1525.
53. Shagdarsuren E, Wellner M, Braesen JH, Park JK, Fiebeler A, Henke N, Dechend R, Gratze P, Luft FC, Muller DN. Complement activation in angiotensin II-induced organ damage. Circ Res. 2005;97:716-724.
54. Melamed J, Kernizan S, Walden PD. Expression of B-cell translocation gene 2 protein in normal human tissues. Tissue Cell. 2002;34:28-32.
55. Li F, Liu J, Park ES, Jo M, Curry TE Jr. The B cell translocation gene (BTG) family in the rat ovary: Hormonal induction, regulation, and impact on cell cycle kinetics. Endocrinology. 2009;150:3894-3902.
56. Park S, Lee YJ, Lee HJ, Seki T, Hong KH, Park J, Beppu H, Lim IK, Yoon JW, Li E, Kim SJ, Oh SP. B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling. Mol Cell Biol. 2004;24:10256-10262.
57. Rouault JP, Falette N, Guéhenneux F, et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet. 1996;14:482-486.
58. Duriez C, Falette N, Audoynaud C, Moyret-Lalle C, Bensaad K, Courtois S, Wang Q, Soussi T, Puisieux A. The human BTG2/TIS21/PC3 gene: Genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene. Gene. 2002;282:207-214.
59. Rapp JP, Joe B. Use of contiguous congenic strains in analyzing compound QTLs. Physiol Genomics. 2012;44:117-120.
60. Flister MJ, Hoffman MJ, Reddy P, Jacob HJ, Moreno C. Congenic mapping and sequence analysis of the Renin locus. Hypertension. 2013;61:850-856.